15-Apr-16 The US is enjoying a record number of tourists from China and some have come for medical treatments they cannot get at home. "This is a relatively new thing in the last two years that many people from China have been coming to the US for medical care. Prior to that, there were very small numbers," said Spencer Koerner, medical director at Cedars-Sinai. [image: Li Ming and Cai Meng / China Daily]

15-Mar-16 Hong Kong's Evergrande Health Industry has entered into a strategic collaboration with Brigham and Women’s Health Care, a teaching hospital of Harvard Medical School, to develop hospital projects in mainland China. The agreement includes strategic guidance on hospital design, clinical and hospital management and staff training, as well as assistance in developing collaborative hospital projects and planning healthcare service models. [image: Reuters]

08-Dec-15 China's implementation of healthcare reforms, changing the approval process for new medical devices and favoring local manufacturers will restrain growth for US medical manufacturers, says Moody's. China's healthcare reforms will be particularly credit negative for companies that make complex devices, such as Medtronic, Boston Scientific and St Jude. [image: Shannon Stapleton / Reuters]

13-Oct-15 As China's growing 40+ population suffers increasingly from lifestyle diseases such as cardiac problems and cancer, many of the wealthy among them will seek treatment in the US or Europe. And many more will spend some of their new found wealth on plastic surgery, dentistry or wellness programs in Korea or Southeast Asia. Chinese medical tourists spent USD10 bn in 2014, only 2.3% of the global total, suggesting that there is a huge potential for further growth in the market. What can hospitals and governments do to tap into this opportunity? [image: Travel Daily News]

03-Nov-15 Chinese diabetes tech firm Sinocare has signed an agreement to acquire Nipro Diagnostics from Japan's Nipro Corp, for USD273 mn. Nipro Diagnostics is based in Florida and manufacturers products for people with diabetes, including a portfolio of blood glucose monitoring technologies. Sinocare CEO Shaobo Li said “Diabetes has become one of the biggest challenges to our public healthcare system and society." [image: Sinocare]